General Information of Drug (ID: DM9WEP5)

Drug Name
LJP-1082 Drug Info
Synonyms Quinacrine azide; 3-Azido-9-((4-(diethylamino)-1-methylbutyl)amino)-7-methoxyacridine; AC1MI36Z; 73332-88-4; 1,4-Pentanediamine, N4-(6-azido-2-methoxy-9-acridinyl)-N1,N1-diethyl-
Indication
Disease Entry ICD 11 Status REF
Hughes syndrome 4A45.Z Discontinued in Phase 1 [1]
Cross-matching ID
PubChem CID
3037609
CAS Number
CAS 73332-88-4
TTD Drug ID
DM9WEP5

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Alpha-D-Mannose DMF5DLW Discovery agent N.A. Investigative [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Beta-2-glycoprotein 1 (APOH) TT2OUI9 APOH_HUMAN Inhibitor [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014345)
2 Emergence of targeted immune therapies for systemic lupus. Expert Opin Emerg Drugs. 2005 Feb;10(1):53-65.
3 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.